common.study.topics.clinical

PET Imaging CCR2 in Lung Inflammation

common.study.values.description

“PET Imaging CCR2 in Lung Inflammation”

The primary objective of this study is to determine the safety of the novel probe 64Cu-DOTA-ECL1i for PET imaging of CCR2 expression.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - 64Cu-DOTA-ECL1i

Radiolabeled probe called 64Cu-DOTA-ECL1i that recognizes CCR2 and propose to image CCR2 in the lung to ultimately guide diagnosis and therapy.

participant.views.study.view.additional

participant.views.study.view.scientific-title

PET Imaging CCR2 in Lung Inflammation

common.study.values.clinical-trial-id

NCT03492762

participant.views.study.view.id

vbmK3e